| Year |
|---|
| Current Assets |
| Cash & Short Term Investments |
| Cash And Cash Equivalents |
| Short Term Investments |
| Net Receivables |
| Inventory |
| Other Current Assets |
| Non-Current Assets |
| Property, Plant & Equipment |
| Goodwill And Intangible Assets |
| Goodwill |
| Intangible Assets |
| Long Term Investments |
| Tax Assets |
| Other Non-Current Assets |
| Other Assets |
| Total Assets |
| Current Liabilities |
| Accounts Payable |
| Short Term Debt |
| Tax Payables |
| Deferred Revenue |
| Other Current Liabilities |
| Total Current Liabilities |
| Total Non-Current Liabilities |
| Long-Term Debt |
| Deferred Revenue |
| Deferred Taxes Liabilities |
| Other Non Current liabilities |
| Total Liabilities |
| Other Liabilities |
| Stockholders Equity |
| Common Stock |
| Retained Earnings |
| Accumulated Other Comprehensive Income/Loss |
| Other Shareholders Equity |
| Total Liabilities and Stockholders Equity |
RPG Life Sciences Limited
RPGLIFE.NS
NSE
1969.5INR-69.2 (-3.39%)
RPGLIFE.NS Financial Statements
Retained Earning Schedule
| Year | 2023 | 2022 |
|---|---|---|
| Retained Earnings (Previous Year) | 2.51B | 1.99B |
| Net Income | 876.6M | 676.4M |
| Stock Repurchases | 0 | 0 |
| Dividend Paid | -198.5M | -158.8M |
| Retained Earnings | 3.18B | 2.51B |
| Other Distributions | 474M | 359.5M |
PPE Schedule
| Year | 2023 | 2022 |
|---|---|---|
| Gross PPE | 1.82B | 1.16B |
| Annual Depreciation | 170.7M | 155M |
| Capital Expenditure | -692.3M | -327.3M |
| Net PPE | 2.34B | 1.34B |
Intangible and Goodwill Schedule
| Year | 2023 | 2022 |
|---|---|---|
| Acquisitions and Adjustments | 0 | 0 |
| Goodwill (Previous Year) | 0 | 0 |
| Goodwill | 0 | 0 |